MIT Spinout C2Sense Raises $8M in Second Closing of Series B
360Dx,
NEW YORK – MIT spinout C2Sense said Wednesday it completed the second closing of its $8 million Series B Round, which will fund…
NEW YORK – MIT spinout C2Sense said Wednesday it completed the second closing of its $8 million Series B Round, which will fund…
NEW YORK – Philadelphia-based PCR instrument and assay developer Biomeme and Kansas City, Missouri-based contract research…
C2Sense, Inc. has published a proof-of-concept study in Frontiers in Public Health demonstrating the sensitivity and…
- C2Sense, Inc. has published a proof-of-concept study in Frontiers in Public Health demonstrating the sensitivity and…